06:01 PM EDT, 06/10/2024 (MT Newswires) -- Maher Masoud, Director, President and CEO, on June 07, 2024, executed a purchase for 100,000 shares in Maxcyte ( MXCT ) for $489,066. Following the Form 4 filing with the SEC, Masoud has control over a total of 100,000 shares of the company, with 100,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1287098/000141588924016259/xslF345X03/form4-06102024_090649.xml

Price: 5.2300, Change: +0.27, Percent Change: +5.44